Publikationen von Frangoul, Haydar

Corbacioglu, Selim , Frangoul, Haydar, Locatelli, Franco, Hobbs, William und Walters, Mark (2023) Defining curative endpoints for transfusion‐dependent β‐thalassemia in the era of gene therapy and gene editing. American Journal of Hematology.

Frangoul, Haydar, Altshuler, David, Cappellini, M. Domenica, Chen, Yi-Shan, Domm, Jennifer, Eustace, Brenda K., Foell, Juergen, de la Fuente, Josu, Grupp, Stephan, Handgretinger, Rupert, Ho, Tony W. , Kattamis, Antonis, Kernytsky, Andrew, Lekstrom-Himes, Julie, Li, Amanda M., Locatelli, Franco, Mapara, Markus Y., de Montalembert, Mariane, Rondelli, Damiano, Sharma, Akshay , Sheth, Sujit, Soni, Sandeep, Steinberg, Martin H., Wall, Donna, Yen, Angela und Corbacioglu, Selim (2021) CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. New England Journal of Medicine 384 (3), S. 252-260. Volltext nicht vorhanden.